{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-093929","form_type":"8-K","ticker":"IVVD","cik":"0001832038","company_name":"Invivyd, Inc.","filed_at":"2024-04-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.549779+00:00","generated_at":"2026-06-03T23:33:33.599339+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Invivyd CEO David Hering departs; Jeremy Gowler appointed Interim CEO","bullets":["Dave Hering ceased as CEO and director effective April 11, 2024; employment ends May 11, 2024; Board searching for permanent CEO.","COO/Commercial Officer Jeremy Gowler appointed Interim CEO effective immediately; will also retain COO/Commercial roles.","Gowler receives $5,000/month additional while serving as Interim CEO; 2024 bonus target increased to 55% on $525k annualized base for interim period.","Board reduced from 9 to 8 members upon Hering's resignation from board.","Press release highlights focus on PEMGARDA launch for COVID PrEP and strong balance sheet."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-093929","json":"https://secwatch.observer/filing/0001193125-24-093929.json","markdown":"https://secwatch.observer/filing/0001193125-24-093929.md","text":"https://secwatch.observer/filing/0001193125-24-093929.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832038/000119312524093929/0001193125-24-093929-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832038/000119312524093929/d748852d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T23:33:33.599339+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"21174b3dba","claim":"Jeremy Gowler was appointed as Interim Chief Executive Officer at Invivyd, Inc..","evidence_excerpt":"the Board appointed Jeremy Gowler, the Company's current Chief Operating Officer and Chief Commercial Officer, as the Company's Interim Chief Executive Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832038/000119312524093929/0001193125-24-093929-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"9996572260","claim":"David Hering resigned as Director at Invivyd, Inc..","evidence_excerpt":"Mr. Hering has also resigned from the Board pursuant to the terms of the Hering Employment Agreement.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832038/000119312524093929/0001193125-24-093929-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}